Caris Life Sciences files for $424M IPO
Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.
Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.
Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.
Tandem, Abbott team on insulin delivery with glucose-ketone sensor Read More »
BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden parachutes—what a CEO would get paid to leave.
Deep Dive: Top Paid Pharma Execs—and Those Who Would Get the Most to Leave Read More »
The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.
Vaccine makers face fresh uncertainty after firing of CDC panel Read More »
Most reductions took place on Friday, while the remaining cuts will take place through July, a spokesperson said. The cuts come three months after Prime acquired the facilities from Ascension.
Prime Healthcare cuts 100 roles at Illinois hospitals Read More »
Con la llegada del verano, las zonas costeras de España se convierten en el escenario ideal para la proliferación de plagas. El aumento de las temperaturas y la humedad son factores que contribuyen a este fenómeno, afectando tanto a hogares como a negocios en estas regiones. Ant …
Consejos para Combatir Plagas con la Llegada del Verano en Zonas Costeras de España Read More »
Concerns about the policies are split along party lines. Still, more than 30% of Republicans said they were concerned the cuts could negatively impact their ability to get and pay for healthcare.
More than half of adults worry Medicaid cuts could hurt healthcare access: KFF Read More »
The company cited Just-Bomholt’s strategic leadership, international experience and ability to drive profitable growth and global expansion as evidence he is the right person for the job.
Robert F. Kennedy Jr.’s removal of all remaining members of the CDC’s Advisory Committee on Immunization Practices raises questions about the upcoming meeting later this month. Analysts fear the committee could be more sympathetic to the HHS Secretary’s anti-vax viewpoints.
‘More Critical’ Vaccine Advisors Expected Following Kennedy’s ACIP Ouster Read More »
Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused five clinical trials. Gilead also stressed that the hold does not impact any other assets in its HIV pipeline.
Gilead’s HIV Combo on Hold, With No Impact on FDA’s Pending Lenacapavir Decision Read More »